HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathleen M Mahoney Selected Research

Kathleen M Mahoney Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 12/2011
7Melanoma (Melanoma, Malignant)
01/2022 - 11/2014
4Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2015 - 04/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2015 - 11/2014
2Hodgkin Disease (Hodgkin's Disease)
04/2015 - 11/2014
1Hypoxia (Hypoxemia)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Leukemia
01/2021
1Tics (Tic)
01/2019
1Lung Neoplasms (Lung Cancer)
04/2015
1Cardiac Tamponade
07/2013
1Breast Neoplasms (Breast Cancer)
12/2011

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2014
5NivolumabIBA
01/2022 - 11/2014
3B7-H1 AntigenIBA
01/2020 - 08/2015
3pembrolizumabIBA
12/2015 - 11/2014
2AntibodiesIBA
01/2020 - 12/2015
2Programmed Cell Death 1 ReceptorIBA
01/2017 - 08/2015
2atezolizumabIBA
04/2015 - 11/2014
2IpilimumabIBA
04/2015 - 11/2014
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1AndrogensIBA
01/2022
1RNA (Ribonucleic Acid)IBA
10/2021
1VaccinesIBA
01/2021
1AntigensIBA
01/2021
1CytokinesIBA
01/2017
1temsirolimusFDA Link
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1TOR Serine-Threonine KinasesIBA
01/2016
1Bevacizumab (Avastin)FDA Link
01/2016
1Coloring Agents (Dyes)IBA
12/2015
1CTLA-4 AntigenIBA
08/2015
1Immune Checkpoint InhibitorsIBA
04/2015
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2015
1Dacarbazine (DIC)FDA LinkGeneric
04/2015
1Monoclonal AntibodiesIBA
04/2015
1LigandsIBA
11/2014
1VemurafenibIBA
07/2013
1Trastuzumab (Herceptin)FDA Link
12/2011
1Hormones (Hormone)IBA
12/2011

Therapy/Procedure

7Therapeutics
01/2022 - 12/2011
5Immunotherapy
10/2021 - 08/2015
1Drug Therapy (Chemotherapy)
12/2011